-
FAKHRAVAC (Persian: واکسن فخرا) is a COVID-19
vaccine developed in Iran by the
Organization of
Defensive Innovation and Research, a
subsidiary of Iran's...
- Full (0)
Emergency (1)
India Travel-only
Malaysia New
Zealand Turkey FAKHRAVAC (or MIVAC), is an
inactivated virus vaccine developed in Iran by the Organization...
-
Medical Sciences Inactivated China June 2021 ZyCoV-D DNA
India August 2021
FAKHRAVAC Inactivated Iran
September 2021 COVAX-19
Subunit Australia, Iran October...
- the
organization developed Iran's
first COVID-19
testing kits and also
FAKHRAVAC, a COVID-19 vaccine. Gambrell, Jon (2020-11-27). "Iran
scientist linked...
- of
Medical Sciences CoronaVac Covaxin COVIran Barekat CoviVac (Russia)
FAKHRAVAC Minhai QazCovid-in
Sinopharm BIBP
Sinopharm WIBP
Turkovac Valneva mRNA...
-
received emergency use
authorization (COVIran Barekat, Pasteurcovac,
FAKHRAVAC, COVAX-19 and Razi Cov Pars). The new
drugs launched in Iran for the treatment...
- V (undelivered)
COVIran Barekat (delivery unfulfilled)
Sinopharm BIBP
FAKHRAVAC Noora "Iranian
capital Tehran holds first public Friday Prayers in almost...
- "great
strides in the
field of
developing COVID-19 vaccine",
later named FAKHRAVAC. He
added that the
center led by
Fakhrizadeh went
through the
first phase...
-
Academy of
Medical Sciences, CoronaVac, Covaxin, CoviVac,
COVIran Barekat,
FAKHRAVAC, Minhai-Kangtai, QazVac,
Sinopharm BIBP, WIBP, Turkovac, and VLA2001....
-
developed in
collaboration with Cuba,
received EUA in Iran on 29 June 2021.
FAKHRAVAC:
received EUA on 9
September 2021. COVAX-19:
developed in collaboration...
